Back |
home / stock / fhtx / fhtx message board
Subject | By | Source | When |
---|---|---|---|
Nice, loaded some 17.48. | Surfacetite | investorshub | 12/13/2021 2:42:05 PM |
$FHTX i BOUGHT 4500 SHARES AVG 17.67 | TheFinalCD | investorshub | 12/13/2021 2:40:06 PM |
Sound the foghorn! > Tutes loading shares all day! | crudeoil24 | investorshub | 12/13/2021 2:38:32 PM |
Loaded 17.11's > Going to run 20.00+ today. | crudeoil24 | investorshub | 12/13/2021 2:36:30 PM |
Amazing! Trading float is 17M according to MarketWatch. | crudeoil24 | investorshub | 12/13/2021 2:27:52 PM |
$FHTX As part of the deal, Eli Lilly | TheFinalCD | investorshub | 12/13/2021 2:21:51 PM |
Foghorn Therapeutics Stock Surges After $1.5B Cancer Pact | crudeoil24 | investorshub | 12/13/2021 2:11:45 PM |
Foghorn Therapeutics Inc. is focused on the discovery | crudeoil24 | investorshub | 12/13/2021 2:10:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Foghorn Therapeutics Inc. Company Name:
FHTX Stock Symbol:
NASDAQ Market:
CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced management's participation in the Jeffe...
Positions company to further leverage strength of platform and advance programs through multiple data readouts and clinical value inflection points Strengthens balance sheet with cash, cash equivalents and short-term investments of $310 million and extends cash runway into 2027 CAMB...
CAMBRIDGE, Mass., May 20, 2024 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (“Foghorn”) (Nasdaq: FHTX) today announced the pricing of a registered direct offering of 12,743,039 shares of its common stock at a price of $5.51 per share, before underwriting discounts and commissions, ...